AGP Executive Report
Last update: 7 hours agoBudget Negotiations: Gov. Mikie Sherrill is signaling she may allow some “pork” spending to be added to her $60.7 billion NJ budget only if other cuts offset it, as lawmakers race to finalize a deal before the June 30 deadline. Medication Safety: The FDA announced a nationwide recall of duloxetine (generic Cymbalta) after tests found elevated levels of a potentially cancer-causing chemical; New Jersey-based Breckenridge Pharmaceuticals is recalling specific lots distributed across the country. Water & Beach Health: Elevated fecal bacteria levels are triggering beach closures and swimming advisories in multiple states, with health risks ranging from GI illness to skin and respiratory infections. Cannabis Access Delays: Cannabis “social consumption” lounges are still waiting on supplemental licenses and local approvals, leaving some operators out of the opening window months after regulations passed. Healthcare Logistics: Fujifilm opened a new endoscopy warehouse in Fairfield, NJ, aiming to expand service capacity and support growing demand. Workplace Wellness Trend: A viral “natural Ozempic” gelatin drink is being promoted online; a NJ dietitian says it may increase fullness temporarily, but experts warn against treating it like proven weight-loss medication.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
